Individual Study / CaG

CARTaGENE

CARTaGENE

CaG logo
Networks -
Datasets -
Variables -
Start Year
2009
Supplementary Information
Some follow-ups are led directly by the CARTaGENE team, while others are conducted in collaboration with external research groups focusing on specific scientific themes. **BALSAC collaboration** * One of these collaborations involves the BALSAC population registry, a genealogical dataset developed at the Université du Québec à Chicoutimi. During both recruitment phases, participants were invited to complete the BALSAC genealogical questionnaire. A second phase of data collection was carried out in 2024 for participants who had not completed the questionnaire at baseline. **CAHHM collaboration** * Another collaboration is with the Canadian Alliance for Healthy Hearts and Minds (CAHHM), a project aiming to understand the association of socio-environmental and contextual factors with cardiovascular risk factors, subclinical vascular disease, and cardiovascular and other chronic disease outcomes. Only a subset of participants residing in Montreal and Quebec were invited to take part in this data collection. **The corresponding data dictionary is available in the “Documents” section below.**
Visit CaG

Members

Download
Investigators Contacts
  • Dr. Simon Gravel
    McGill University
  • Dr. Vikki Ho
    Centre de recherche du centre Centre hospitalier de l'Université de Montréal
  • Dr. Guillaume Lettre
    Montreal Heart Institute Research Centre
  • Bureau d'accès
    CARTaGENE

Design

Study design
Cohort
Follow Up
The first recruitment phase took place between July 2009 and March 2011, followed by additional data collections in 2009–2014 (BALSAC collaboration), 2011, and 2012. A second recruitment phase occurred from November 2012 to February 2015. Participants were subsequently followed up in 2015–2017, 2016–2019, and through multiple COVID-19 follow-ups conducted in 2020, 2021, and 2022.
Supplementary Information

Marker Paper

Awadalla P, Boileau C, Payette Y, et al. Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. Int J Epidemiol, 2013; 42:1285-1299.

PUBMED 23071140

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
43,034
Number of Participants with Biological Samples
30,226
Supplementary Information

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other
* Genetic data (Genotyping, RNA-sequencing, Whole genome sequencing) * Medical imaging (brain and heart MRI, ECG)

Availability of access information

On the study website : http://www.cartagene.qc.ca/en

By contacting the study representative

Sector of research

Possible Access to Data Possible Access to Biosamples
Investigators from the public sector
Investigators from the private sector
Investigators from not-for-profit organization

Transfer

Possible Access to Data Possible Access to Biosamples
Can leave the study facility
Can leave the country

Cost

Possible Access to Data Fixed Cost
Possible Access to Biosamples Fixed Cost

Cost reduction for co-analyses

Possible Access to Data
Possible Access to Biosamples

Timeline

CaG population

Selection Criteria
Minimum age
40
Maximum age
69
Newborns
Twins
Countries
  • Canada
Territory
Montreal, Quebec, Sherbrooke and Saguenay for recruitment phase A. Trois-Rivières and Gatineau were added for recruitment phase B.
Ethnic Origin
Health Status
Other Criteria
Participants were excluded if they were not registered in the FIPA files, if they resided outside the selected regions, lived in First Nations Reserves or long-term healthcare facilities or were in prison.

Recruitment

Sources of recruitment
  • General population
General Population
  • Selected sample
  • Random digit dialing
Supplementary Information
Participants were randomly chosen to be broadly representative of the population based on provincial health insurance registries—FIPA files (fichier administratif des inscriptions des personnes assurées de la Régie de l’assurance maladie du Québec (RAMQ)).

Number of Participants

Number of Participants
43,034
Number of Participants with Biological Samples
30,226
Supplementary Information about selection criteria
Recruitment (2009):  19,985 participants
BALSAC collaboration (2009):  11,467 participants
Residential history (2011):  11,653 participants
Occupational history (2011):  10,891 participants
Nutrition (2012):  10,073 participants
Recruitment (2012):  23,049 participants
CAHHM collaboration (2015):  1,746 participants
Health follow-up (2016):  17,004 participants
COVID-19 (2020-06):  8,187 participants
COVID-19 (2021-03):  6,264 participants
COVID-19 (2021-10):  672 participants
COVID-19 (2022-03):  3,253 participants
COVID-19 (2022-04):  580 participants
Data Collection Events
# Name Description Start End
0 CaG - Recruitment - 2009 Information about socio-demographic characteristics, lifestyle, mental health, psychosocial environment, personal and family history of disease, healthcare utilization, medication use, and women ... 2009-07 2011-03
1 CaG - BALSAC collaboration - 2009 Information about places and dates of birth, marriage and death for the participant, their parents, grandparents and great-grandparents is collected though questionnaire. Linkage with the ... 2009-07 2024-06
2 CaG - Occupational and residential history - 2011 Information is collected on about job characteristics, employment duration, environmental exposures at work, means of transportation, residence location, duration of residence occupancy and ... 2011 2011
3 CaG - Nutrition - 2012 Information about foods and beverages consumed, consumption of vitamins and supplements and usage of water treatment devices is collected. 2012 2012
4 CaG - Recruitment - 2012 Information about socio-demographic characteristics, lifestyle, mental health, psychosocial environment, personal and family history of disease, healthcare utilization, medication use, women and ... 2012-11 2015-02
5 CaG - CAHHM collaboration - 2015 Information about socio-demographic characteristics, lifestyle, psychosocial environment, beliefs and values, personal history of disease, healthcare utilization and medication use is collected ... 2015-03 2017-07
6 CaG - Health follow-up - 2016 Information about socio-demographic factors, lifestyle, mental health, psychosocial environment, personal and family history of disease, healthcare utilization, medication use, women and men’s ... 2016-12 2019-08
7 CaG - COVID-19 - 2020-06 Information on COVID-19 test results/suspected infection, symptoms experienced (if any), hospitalizations or received medical care, potential source of exposure, impact of pandemic on job status ... 2020-06 2020-07
8 CaG - COVID-19 - 2021-03 Information is collected on COVID-19 test results/suspected infection, symptoms experienced (if any), hospitalizations or received medical care, potential source of exposure, COVID vaccination, ... 2021-03 2021-05
9 CaG - COVID-19 - 2021-10 Data is collected for a subgroup of participants. Information on COVID-19 test results/suspected infection, symptoms experienced (if any), hospitalizations or received medical care, potential ... 2021-10 2021-12
10 CaG - COVID-19 - 2022-03 Data is collected for a subset of participants. Information on COVID-19 test results/suspected infection, symptoms experienced (if any), hospitalizations or received medical care, potential ... 2022-03 2022-07
11 CaG - COVID-19 - 2022-04 Data is collected for a subset of participants. Information on COVID-19 test results/suspected infection, symptoms experienced (if any), hospitalizations or received medical care, COVID ... 2022-04 2022-06
12 CaG - Nutrition - 2024 NutriQuébec is the largest nutrition and population health study ever conducted in Quebec. NutriQuébec collects information on a wide range of health-related factors from thousands of Quebec ... 2024-06 2024-09
13 CaG - Nutrition - 2025 NutriQuébec is the largest nutrition and population health study ever conducted in Quebec. NutriQuébec collects information on a wide range of health-related factors from thousands of Quebec ... 2025-06 2025-09

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information
Cognitive functioning
Personality
Psychological distress and emotions
Other psychological measures and assessments
Perception of health
Quality of life
Life course development
Functional limitations
Other perception of health, quality of life and functional limitation-related information
Tobacco
Alcohol
Drugs
Nutrition
Breastfeeding
Physical activity
Sleep
Sexual behaviours and orientation
Technological devices
Misbehaviour and criminality
Other and unspecified lifestyle information

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Twin
Marital/partner status
Family and household structure
Education
Residence
Birthplace
Citizenship and immigrant status
Ethnicity, race and religion
Language
Labour force and retirement
Income, possessions, and benefits
Other socio-demographic and economic characteristics

Lifestyle and behaviours

Tobacco
Alcohol
Drugs
Nutrition
Breastfeeding
Physical activity
Transportation
Sleep
Leisure activities
Technological devices
Other and unspecified lifestyle information

Birth, pregnancy and reproductive health history

Puberty, menstruation, menopause and andropause
Contraception
Pregnancy, delivery and birth
Fertility and sexual health

Perception of health, quality of life, development and functional limitations

Perception of health
Quality of life
Functional limitations
Use of assistive devices
Other perception of health, quality of life and functional limitation-related information

Diseases

Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Endocrine, nutritional and metabolic diseases (E00-E90)
Mental and behavioural disorders (F00-F99)
Diseases of the nervous system (G00-G99)
Diseases of the eye and adnexa (H00-H59)
Diseases of the ear and mastoid process (H60-H95)
Diseases of the circulatory system (I00-I99)
Diseases of the respiratory system (J00-J99)
Diseases of the digestive system (K00-K93)
Diseases of the skin and subcutaneous tissue (L00-L99)
Diseases of the musculoskeletal system and connective tissue (M00-M99)
Diseases of the genitourinary system (N00-N99)
Pregnancy, childbirth and the puerperium (O00-O9A)
Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
Injury, poisoning and certain other consequences of external causes (S00-T98)
Diseases without precise specification or falling into multiple categories

Symptoms and signs

Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
Symptoms and signs involving the digestive system and abdomen (R10-R19)
Symptoms and signs involving the skin and subcutaneous tissue (R20-R23)
Symptoms and signs involving nervous and musculoskeletal systems (R25-R29)
Symptoms and signs involving cognition, perception, emotional state and behaviour (R40-R46)
Symptoms and signs involving speech and voice (R47-R49)
General symptoms and signs (R50-R69)
Symptoms related to multiple categories

Medication and supplements

Medication and supplement intake
Posology and protocol of administration
Other and unspecified pharmacological interventions

Non-pharmacological interventions

Surgical interventions
Radiological interventions
Educational and health promotion interventions
Laboratory diagnosis interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Visits to health professionals
Hospitalizations
Other health and community care

Death

Vital status
Cause of death

Physical measures and assessments

Physical characteristics
Anthropometry
Circulation and respiration
Muscles, skeleton and mobility
Brain and nerves
Skin and subcutaneous tissue
Other physical measures and assessments

Laboratory measures

Hematology
Biochemistry
Virology
Immunology

Cognition, personality and psychological measures and assessments

Cognitive functioning
Psychological distress and emotions
Other psychological measures and assessments

Life events, life plans, beliefs and values

Life events
Beliefs and values

Preschool, school and work life

Preschool life
Work life

Social environment and relationships

Social network
Social participation
Social support
Other social environment characteristics

Physical environment

Housing characteristics
Built environment/neighbourhood characteristics
Workplace characteristics
Radiation exposure
Chemical exposure
Biological exposure
Other physical environment characteristics

Administrative information

Identifiers
Date and time-related information
Questionnaire and interview-related information
Physical and cognitive measure and biosample-related information
Data and sample collection center-related information
Other administrative information

Cognitive functioning

Montreal Cognitive Assessment

Psychological distress and emotions

Generalized Anxiety Disorder Scale
Patient Health Questionnaire

Quality of life

Short-Form 36 Health Survey

Nutrition

Canadian Diet History Questionnaire
Canadian Healthy Eating Index
Food Frequency Questionnaire (different forms)

Physical activity

International Physical Activity Questionnaire